OFF-BRAND IMATINIB: A BUDGET-FRIENDLY ALTERNATIVE?

The arrival of common imatinib represents a notable possibility for patients battling a certain type of cancer and other illnesses. Original brand-name imatinib, often referred to as Gleevec, carries a steep price tag, frequently making it accessibility for some individuals. Off-brand versions, u